MEMORY AND COGNITIVE FUNCTION FOLLOWING ADJUVANT OOPHORECTOMY/TAMOXIFEN AND ADJUVANT CHEMOTHERAPY

Project Leader:

 


Anne McVey, Ph.D.

Assistant Professor of Clinical Psychiatry
Division of Hematology Oncology
Department of Internal Medicine
The Ohio State University
Columbus, Ohio



Status:
  • Proposed ancillary project to Inflammatory Breast Cancer Phase III study and
  • Proposed ancillary project to Timing of Adjuvant Surgical Oophorectomy in Pre-menopausal Women study

    Funds Needed:
  • $60,000 for treatment study and analysis in two separate control groups in Philippines and Morocco.

    Study Background:
    Patients with breast cancer often complain of mental changes that accompany disease treatment, using phrases like “always feeling in a fog” or “chemo-brain” to describe their experiences.  These changes in concentration, memory, decision making, and judgment (“cognitive functioning”) negatively impact women’s overall quality of life, their ability to return to normal activities at work and in the home. These mental changes interfere with patients’ ability to make complex decisions about their cancer treatments.  Only recently have researchers begun to take these complaints seriously enough to try and study them in rigorous ways.  To date, the main focus of the very limited research has been on the side effects women experience after chemotherapy.

    Study Organization:
    We have developed a 40-minute comprehensive group of previously validated tests, focusing on attention span, information processing and verbal memory.  The testing can be used on women regardless of their language skills because the test components are not dependent on ability to read or speak a particular language. Each of the tests focuses on a particular area of cognitive functioning that appears to be affected by cancer treatments.

    Two distinct patient samples will be enrolled.  Each will receive specific treatment, either hormonal treatment or intense chemotherapy.  This allows the cognitive effects to be isolated and properly evaluated. 

    Hormonal treatment organization:
  • Study 250 young women just diagnosed with breast cancer in the Philippines, for whom adjuvant hormonal treatment involving surgery to remove their ovaries followed by anti-estrogen therapy with tamoxifen is planned. 
  • Administer the series of cognitive testing at four different stage of their treatment.
      1. pre-surgery
    2. 3 weeks post surgery
    3. 6 months post surgery
    4. in 2 year follow-up evaluations 
  • In the same way, we will also study a group of 250 women undergoing surgery for non-malignant conditions.

    Chemotherapy treatment organization:
  • Study 250 women just diagnosed with serious inflammatory breast cancer in Morocco, for whom intense chemotherapy is needed to control and hopefully cure the disease. 
  • Administer the series of cognitive testing at four different stage of their treatment.
      1. pre-surgery
    2. 3 weeks post surgery
    3. 6 months post surgery
    4. in 2 year follow-up evaluations 
  • Similarly, a control group of 250 Moroccan women receiving no chemotherapy will be studied over time.

     

  • Home page Donate Volunteer FAQs Contacts